Anti-inflammatory composition for aiding and promoting the healing of chronic ulcerative lesions
AssigneePebisut De Mexico S.A. DE C.V.
InventorJorge Cueto García
Life of this patent
Estimating the term…
Abstract
The invention relates to an anti-inflammatory composltwn compring: 53 wt.-% maltodextrin in relation to the total weight; IO-12 wt.-% zinc oxide as a thixotropic agent; 1.8 wt.-% maltose; 0.0002 wt.-% sodium; 0.0002 wt.-% potassium; 0.0002 wt.-calcium; 0.0002 wt.-% phosphor; and 0.0006 wt.-% magnesium. The composition has an application viscosity in the range of 12,000-33,000 cp, a pH of between 5.6 and 6.9, a TGA of 61.12 and bond strength at 24 hours of 6 MPa.
Claims11
An anti-inflammatory and bacteriostatic composition to be used in the preparation of a Medical Device type III short time for the treatment of chronic ulcerative lesions such as diabetic foot and varicose venous ulcers, the composition containing not hygroscopic maltodextrin as item of dispersion, and where the anti-inflammatory and bacteriostatic composition includes a structural component that provides thixotropy to the composition, wherein said composition contains 80-97% of the weight as an item of dispersion, and where such not higroscopic maltodextrin contains 45-75% of solid contents, and wherein the composition contains 1.8% of maltose, 0.0002% by weight of sodium, 0.0002% weight of potassium, 0.0002% by weight of calcium, 0.0002% by weight of phosphorus, and 0.0006% by weight of magnesium and wherein the anti-inflammatory and bacteriostatic composition has a viscosity greater than 100,000 cp in resting state and an application viscosity in the range of 15,000 to 27, 000 cp, a pH of 4 to 7, a TGA of 61.12 and presents an adhesiveness at 24 hours of 6 MPa.
An anti-inflammatory and bacteriostatic composition according to claim 10, wherein the structural component that provides thixotropy to the composition is zinc oxide.
Dependencies are inferred from the claim text.